Navigation Links
Human Genome Sciences Presents New Data Showing Anti-Tumor Activity And Safety Of Trail Receptor Antibodies In Combination With Chemotherapy
Date:10/24/2007

nts within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are based on Human Genome Sciences' current intent, belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the Company will continue to face risks related to animal and human testing, to the manufacture of ABthrax and to FDA concurrence that ABthrax meets the requirements of the ABthrax contract. If the Company is unable to meet the product requirements associated with the ABthrax contract, the U.S. government will not be required to reimburse the Company for the costs incurred or to purchase any ABthrax doses. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or revise the information contained in this announcement whether as a result of new information, future events or circumstances or otherwise.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Testing for Human Papillomavirus
2. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
3. Phase II Results Show Once-Daily Dosing of Human GLP-1 Analog Liraglutide, Brings Patients to A1c Target
4. Apollos human proteins boost stem cell research
5. Advanced Cell Technology Develops First Human Embryonic Stem Cell Line without Destroying an Embryo
6. Modigene Announces Successful Completion of Pharmacokinetic & Pharmacodynamic Pre-Clinical Experiments for Proprietary Long-Acting Human Growth Hormone, Long-acting Interferon Beta and Long-acting Erythropoietin
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Research Documents Scalable Production, Survival Following Engraftment and Positive Impact on Cardiac Function in Infarcted Rats for Gerons Human Embryonic Stem Cell-Based Therapeutic for Heart Failure
9. Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B Showed Significant Reductions in Disease Activity in Patients with Active Systemic Lupus Erythematosus
10. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
11. Research Indicates Gerons Human Embryonic Stem Cell-Based Therapeutic for Spinal Cord Injury Evades Direct Attack by the Human Immune System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22, 2015  Amgen (NASDAQ: AMGN ) ... year 2014 financial results on Tuesday, Jan. 27, 2015, after the ... by a conference call with the investment community at 2 p.m. ... A. Bradway , chairman and chief executive officer, and other members ...
(Date:1/22/2015)... Calif. , Jan. 22, 2015 Increasing sophistication ... continued consolidation of localization purchasing in 2015, says ... According to a recent study by market research firm ... a single-source solution for their translation and localization needs. ...
(Date:1/22/2015)... ( http://www.researchandmarkets.com/research/w25xpc/allergy ) has announced the addition of ... by End User - Global Forecast to 2019" report ... market is valued at $1,228.58 million in 2014 and is ... $2,230.72 million by 2019. Allergy diagnostics is used to determine ...
Breaking Medicine Technology:Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results 2Moravia Sees Single-Sourcing as Key Localization Trend in 2015 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 2Global Allergy Diagnostics (Immunoassay Analyzer, Luminometer, Assay Kit, Consumables) Market - Forecast to 2019 3
... BELGRADE, Mont., Nov. 15, 2010 Bacterin International Holdings, ... BIHI ), a developer of anti-infective coatings for ... financial results for its third quarter ended September 30, ... the reverse merger transaction reported in the Company,s Form ...
... Corporation (Nasdaq: PRXL ), a leading global biopharmaceutical ... 2010 Scrip Award for "Clinical Research Team of ... at the sixth annual Scrip Awards ceremony, hosted ... information service for the global pharmaceutical industry, on November 4, ...
Cached Medicine Technology:Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 2Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 3Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 4Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 5Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 6Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 7Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 8Bacterin International Holdings, Inc. Reports Third Quarter 2010 Financial Results 9PAREXEL Wins Clinical Research Team of the Year Scrip Award 2PAREXEL Wins Clinical Research Team of the Year Scrip Award 3PAREXEL Wins Clinical Research Team of the Year Scrip Award 4PAREXEL Wins Clinical Research Team of the Year Scrip Award 5
(Date:1/22/2015)... 22, 2015 Autocarinsurancebest.com has released a new ... commercial auto insurance policy . , Auto insurance quotes ... It is no longer necessary to call an agent or ... available online on a single website: http://autocarinsurancebest.com/ . , ...
(Date:1/22/2015)... NY (PRWEB) January 22, 2015 ... of Sports Medicine flagship journal Medicine & Science ... L-Citrulline before exercise may help reduce gastrointestinal (GI) ... 1 , Participants in the double-blind, placebo-controlled ...
(Date:1/22/2015)... Four years since the release of their debut ... the marriage of Avasa & Matthew Love – the duo are ... for release through White Swan Records on February 24, 2015. , ... sacred path available to all of us to walk out of ...
(Date:1/22/2015)... January 22, 2015 JJsHouse.com is a famous ... Today, the business announces its latest collection of wedding ... “The most important issue is the wedding dress on your ... in a woman’s life. Every bride wants to find the ...
(Date:1/22/2015)... USA (PRWEB) January 22, 2015 State ... statewide data management system with support from GEOSYSTEMS, a ... The new solution will leverage Hexagon Geospatial’s ERDAS ... vector data as well as point clouds and documents. ...
Breaking Medicine News(10 mins):Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... Oct. 11 At "Managing Quality to,Drive Growth," ... LLC,s,Global Benchmarking Council (GBC), executives from 20 leading ... for quality and,growth; product innovation excellence; process simplification ... successes in integrating quality into,sales, marketing and new ...
... ALOKA Co., Ltd., a pioneer in the,development ... Masanobu Tada as President, and Carlos Faustmann as ... the company,s,wholly-owned European headquarters in Zug, Switzerland, with ... Global Marketing of the company as,general manager since ...
... YORK, Oct. 10 Molina Healthcare Inc. (NYSE: MOH ... in the S&P,SmallCap 600 after the close of trading on ... constituent LKQ Corp. (Nasdaq: LKQX ) in,a deal that ... final,approvals. Standard & Poor,s will monitor this transaction, and ...
... PORTLAND, Ore., Oct. 10 Mark Ganz, President and ... a prominent group of,thought leaders and health policy experts ... major initiative to reframe and broaden the,national dialogue on ... and beyond. The Aspen Health Stewardship Project will ...
... performed equally in high-tech tests , , WEDNESDAY, Oct. 10 ... runners should follow Prince Charming,s lead and consider a ... , Using high-tech methods, a team of Scottish scientists ... between $80 pairs of running shoes and pairs made ...
... to Protect Health Benefit, MARYSVILLE, Calif., Oct. 10 ... to announce the filing of a,formal grievance over the ... caregivers earlier this year. Because of the county,s ... residents who are elderly or have disabilities must play,a ...
Cached Medicine News:Health News:Mastering Challenges & Measuring Successes for Quality Initiatives in Sales, Marketing and Product Development 2Health News:ALOKA Appoints New Management in Europe 2Health News:Standard & Poor's Announces Change to U.S. Index 2Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 2Health News:Regence CEO to Chair National Effort Promoting Broader Health Care Stewardship 3Health News:Pricey Running Shoes Not Worth It: Study 2Health News:Pricey Running Shoes Not Worth It: Study 3Health News:Pricey Running Shoes Not Worth It: Study 4Health News:Caregivers Demand County Honor Their Contract 2
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Trueview Classic is,lightweight, comfortable and durable....
Mounted on a fully adjustable molded,headband with crown strap and comfort,cushions, the sturdy Halogen III Classic is,lightweight, comfortable and durable....
Mounted on a sturdy, molded headband,the Classic has a fully adjustable,crown strap and cushioning that adds,to your comfort....
... InterGro DBM putty is a ... most trusted names in human tissue ... in bone grafting technology. InterGro ... lipid carrier (lecithin) to deliver a ...
Medicine Products: